Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Journal of Clinical Pharmacology|March 22, 2021
Effects of Hepatic Impairment on the Pharmacokinetics of Abrocitinib and Its MetabolitesEllen Q Wang, Vu Le, Melissa O'Gorman, et al.
British Journal of Clinical Pharmacology|May 7, 2025
Drug-drug interaction profile of ritlecitinib as perpetrator and victim through cytochrome P450Vivek S Purohit, Yeamin Huh, Martin E Dowty, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 13, 2013
Preclinical to clinical translation of tofacitinib, a Janus kinase inhibitor, in rheumatoid arthritisMartin E Dowty, Michael I Jesson, Sarbani Ghosh, et al.
Pharmacology Research & Perspectives|December 14, 2019
Janus kinase inhibitors for the treatment of rheumatoid arthritis demonstrate similar profiles of in vitro cytokine receptor inhibitionMartin E Dowty, Tsung H Lin, Michael I Jesson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 8, 2024
The Metabolism and Disposition of Brepocitinib in Humans and Characterization of the Formation Mechanism of an Aminopyridine MetaboliteMartin E Dowty, Ruolun Qiu, Alyssa Dantonio, et al.
British Journal of Clinical Pharmacology|January 12, 2012
Lack of effect of tofacitinib (CP-690,550) on the pharmacokinetics of the CYP3A4 substrate midazolam in healthy volunteers: confirmation of in vitro dataPankaj Gupta, Christine Alvey, Rong Wang, et al.
Journal of Clinical Pharmacology|October 12, 2021
Effects of Renal Impairment on the Pharmacokinetics of Abrocitinib and Its MetabolitesEllen Q Wang, Vu Le, Jennifer A Winton, et al.
Pageof 6